Intelligent Bio Solutions Inc.
INBS
$2.20
$0.020.92%
| Weiss Ratings | INBS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | INBS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Fair | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Good | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | INBS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 3.23 | |||
| Price History | INBS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 7.84% | |||
| 30-Day Total Return | 49.66% | |||
| 60-Day Total Return | 44.74% | |||
| 90-Day Total Return | 48.65% | |||
| Year to Date Total Return | 56.03% | |||
| 1-Year Total Return | -52.07% | |||
| 2-Year Total Return | -93.52% | |||
| 3-Year Total Return | -98.63% | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -53.97% | |||
| 52-Week Low % Change | 120.00% | |||
| Price | INBS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $4.78 | |||
| 52-Week Low Price | $1.00 | |||
| 52-Week Low Price (Date) | Aug 16, 2024 | |||
| 52-Week High Price (Date) | Mar 13, 2024 | |||
| Valuation | INBS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 11.61M | |||
| Enterprise Value | 9.83M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -3.55 | |||
| Earnings Per Share Growth | -96.73% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 3.29 | |||
| Price/Book (Q) | 2.42 | |||
| Enterprise Value/Revenue (TTM) | 3.24 | |||
| Price | $2.20 | |||
| Enterprise Value/EBITDA (TTM) | -1.01 | |||
| Enterprise Value/EBIT | -0.91 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | INBS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 4.54M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | INBS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 646 828 8258 | |||
| Address | 135 West, 41ST Street New York, NY 10036 | |||
| Website | ibs.inc | |||
| Country | United States | |||
| Year Founded | 2016 | |||
| Profitability | INBS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -354.79% | |||
| Profit Margin | -352.87% | |||
| Management Effectiveness | INBS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -76.77% | |||
| Return on Equity | -- | |||
| Income Statement | INBS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 3.03M | |||
| Total Revenue (TTM) | 3.03M | |||
| Revenue Per Share | $0.67 | |||
| Gross Profit (TTM) | 1.56M | |||
| EBITDA (TTM) | -9.77M | |||
| EBIT (TTM) | -10.76M | |||
| Net Income (TTM) | -10.70M | |||
| Net Income Avl. to Common (TTM) | -10.70M | |||
| Total Revenue Growth (Q YOY) | -20.49% | |||
| Earnings Growth (Q YOY) | -14.19% | |||
| EPS Diluted (TTM) | -3.55 | |||
| EPS Diluted Growth (Q YOY) | 76.09% | |||
| Balance Sheet | INBS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 2.24M | |||
| Cash Per Share (Q) | $0.49 | |||
| Total Current Assets (Q) | 4.06M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 4.20M | |||
| Current Ratio (Q) | 0.922 | |||
| Book Value Per Share (Q) | $0.91 | |||
| Total Assets (Q) | 8.68M | |||
| Total Current Liabilities (Q) | 4.40M | |||
| Total Debt (Q) | 626.00K | |||
| Total Liabilities (Q) | 4.48M | |||
| Total Common Equity (Q) | 4.37M | |||
| Cash Flow | INBS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -173.60K | |||
| Cash from Financing (TTM) | 11.45M | |||
| Net Change in Cash (TTM) | 1.12M | |||
| Levered Free Cash Flow (TTM) | -6.30M | |||
| Cash from Operations (TTM) | -10.10M | |||
